Moderna announced that it's launched early-stage clinical trials of an HIV mRNA vaccine.
"We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna's mRNA platform," Dr. Mark Feinberg, president and CEO of IAVI, said in a statement."The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine."Nearly 38 million people worldwide -- including about 1.3 million in the U.
Today, HIV is much more manageable with medications that can reduce viral loads to undetectable so the virus can't be transmitted, as well as pills that can be taken to prevent infecting those who are HIV-negative. The new vaccine uses mRNA, or messenger RNA, which teaches the body's cells how to make proteins that trigger immune responses.
The hope is this process can induce specific white blood cells, called B cells, which can then turn into what are known as broadly neutralizing antibodies that can neutralize the virus.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna Launches Clinical Trials for HIV VaccineHuman clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week.
Les mer »
Moderna launches clinical trial for HIV vaccine that uses mRNA technologyModerna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants in the Phase I trial were given doses at George Washington University School of Medicine and Health Sciences in Washington, D.C., according to a company statement.
Les mer »
Moderna begins human trials for HIV vaccineModerna has launched early-stage human trials for an mRNA vaccine to treat HIV, the company announced to investors on Thursday.
Les mer »
Moderna’s mRNA HIV Vaccine Begins Early-Stage Human TrialsModerna has begun clinical trials of its HIV vaccine that employs messenger RNA, much like the company's successful COVID-19 vaccine.
Les mer »
Moderna launches clinical trial for HIV vaccine that uses mRNA technologyModerna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants in the Phase I trial were given doses at George Washington University School of Medicine and Health Sciences in Washington, D.C., according to a company statement.
Les mer »
Moderna Launches Clinical Trials for HIV VaccineHuman clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week.
Les mer »